You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TNGX Exercise Disclosure
Crystal Adam · SEC Form 4 · Filed Oct 5, 2026
Exercise
Calculated transaction value
$140.4K
Crystal Adam President, R&d
TNGX
Tango Therapeutics
TNGX
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
TNGX daily price context
Close on/before transaction
$24.45
Oct 1, 2026
First close after public filing
$21.9
Oct 6, 2026
30-day return after filing
+5.84%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 27,000 shares @ $5.2
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-414500
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$801.2K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tango Therapeutics, Inc. TNGX | Sale | Oct 1, 2026 | $645.6K |
| Tango Therapeutics, Inc. TNGX | Sale | Oct 1, 2026 | $15.19K |
| Tango Therapeutics, Inc. TNGX | Exercise | Oct 1, 2026 | $0 |
| Tango Therapeutics, Inc. TNGX Current | Exercise | Oct 1, 2026 | $140.4K |